- E-postgeir.skeie@uib.no
- Telefon+47 55 97 50 75
- BesøksadresseLars Hilles gate 35015 Bergen
- PostadressePostboks 78005020 Bergen
Vitenskapelig artikkel
- (2023). NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease. Nature Communications.
- (2023). Growth dynamics of incidental meningiomas: A prospective long-term follow-up study. Neuro-Oncology Practice. 238-248.
- (2022). The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. Cell Metabolism. 396-407.e6.
- (2020). A simple score to estimate the likelihood of pseudoprogression vs. recurrence following stereotactic radiosurgery for brain metastases: The Bergen Criteria. Neuro-Oncology Advances (NOA). 10 sider.
- (2019). Subjective judgments of rhythmic complexity in Parkinson's disease: Higher baseline, preserved relative ability, and modulated by tempo. PLOS ONE. 1-21.
- (2019). Neuroplastic effects in patients with traumatic brain injury after music-supported therapy. Frontiers in Human Neuroscience. 1-11.
- (2019). Compensatory task-specific hypersensitivity in bilateral planum temporale and right superior temporal gyrus during auditory rhythm and omission processing in Parkinson?s disease. Scientific Reports. 1-9.
- (2019). A prospective study of the natural history of incidental meningioma-Hold your horses! Neuro-Oncology Practice. 438-450.
- (2018). Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study. Journal of Neurosurgery. 71-83.
- (2018). Myasthenia gravis and infectious disease. Journal of Neurology. 1251-1258.
- (2018). Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease. Acta Neurologica Scandinavica. 508-514.
- (2018). HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis. Acta Neurologica Scandinavica. 219-226.
- (2018). Effects of music production on cortical plasticity within cognitive rehabilitation of patients with mild traumatic brain injury. Brain Injury. 634-643.
- (2018). Abnormal phasic activity in saliency network, motor areas, and basal ganglia in Parkinson's disease during rhythm perception. Human Brain Mapping. 916-927.
- (2017). Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage. Acta Neuropathologica. 409-425.
- (2017). Multiple antibody detection in `seronegative? myasthenia gravis patients. European Journal of Neurology. 844-850.
- (2017). Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms. Journal of Neurology. 955-962.
- (2017). Familial aggregation of Parkinson's disease may affect progression of motor symptoms and dementia. Movement Disorders. 241-245.
- (2016). Myasthenia gravis and amyotrophic lateral sclerosis: A pathogenic overlap. Neuromuscular Disorders. 337-341.
- (2016). Gene polymorphisms for both auto-antigen and immune-modulating proteins are associated with the susceptibility of autoimmune myasthenia gravis. Molecular Neurobiology. 10 sider.
- (2016). Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients. Journal of Neuroimmunology. 51-57.
- (2015). En kvinne med kraftsvikt i armer og bein. Tidsskrift for Den norske legeforening.
- (2014). The factor structure of the UPDRS motor scores changes during early Parkinson's disease. Parkinsonism & Related Disorders. 617-621.
- (2013). Treatment in early Parkinson's disease: the Norwegian ParkWest study. Acta Neurologica Scandinavica. 107-113.
- (2013). Parkinson disease: Associated disorders in the Norwegian population based incident ParkWest study. Parkinsonism & Related Disorders. 53-55.
- (2013). Gamma knife surgery of colorectal brain metastases: a high prescription dose of 25 Gy may improve growth control. World Neurosurgery. 525-536.
- (2013). Autonomic symptoms and dopaminergic treatment in de novo Parkinson's disease. Acta Neurologica Scandinavica. 290-294.
- (2012). The Effect of Group Music Therapy on Mood, Speech, and Singing in Individuals with Parkinson's Disease - A Feasibility Study. The Journal of music therapy. 278-302.
- (2012). Focal myositis - A neurogenic phenomenon? Neuromuscular Disorders. 350-354.
- (2012). Effects of music therapy on facial expression of individuals with Parkinson's disease: A pilot study. Musicae Scientiae. 392-400.
- (2011). Myasthenia gravis; a review of available treatment approaches. Autoimmune Diseases. 8 sider.
- (2011). Myasthenia gravis autoantibodies have a target also outside the neuromuscular junction. Advances in Clinical Neuroscience & Rehabilitation. 14-15.
- (2011). Investigation for RAPSN and DOK-7 mutations in a cohort of seronegative myasthenia gravis patients. Muscle and Nerve. 574-577.
- (2011). Gamma Knife Surgery of Colorectal Brain Metastases: A High Prescription Dose of 25 Gy May Improve Growth Control. World Neurosurgery. 684-691.
- (2011). Gamma Knife Surgery in Brain Melanomas: Absence of Extracranial Metastases and Tumor Volume Strongest Indicators of Prolonged Survival. World Neurosurgery. 684-691.
- (2011). Autonomic and sensory symptoms and signs in incident, untreated Parkinson’s Disease : frequent but mild. Movement Disorders. 65-72.
- (2010). Guidelines for treatment of autoimmune neuromuscular transmission disorders. European Journal of Neurology. 893-902.
- (2010). Gamma knife surgery of meningiomas involving the cavernous sinus: long-term follow-up of 100 patients. Neurosurgery. 661-669.
- (2010). Differential Effect of Environmental Risk Factors on Postural Instability Gait Difficulties and Tremor Dominant Parkinson's Disease. Movement Disorders. 1847-1852.
- (2009). Myasthenia gravis in the elderly. Aging Health. 561-568.
- (2009). Interleukin-10 promoter polymorphisms in myasthenia gravis. Journal of Neuroimmunology. 63-66.
- (2009). Aphasia among Young Patients with Ischemic Stroke on Long-term Follow-up. Journal of Stroke & Cerebrovascular Diseases. 247-250.
- (2008). Titin and ryanodine receptor antibodies and neurmuscular involvement in myasthenia gravis. Future Neurology. 87-92.
- (2008). CRMP5 antibodies in patients with small-cell lung cancer or thymoma. Cancer Immunology and Immunotherapy. 227-232.
- (2007). Polygenic disease associations in thymomatous myasthenia gravis. Archives of Neurology. 1729-1733.
- (2006). Titin and ryanodine receptor antibodies in myasthenia gravis. Acta Neurologica Scandinavica. 19-23.
- (2006). Morphological effects of myasthenia gravis patient sera on human muscle cells. Muscle and Nerve. 93-103.
- (2006). Guidelines for the treatment of autoimmune neuromuscular transmission disorders. European Journal of Neurology. 691-699.
- (2006). Effects of myasthenia gravis patient sera on human myoblast cultures. Acta Neurologica Scandinavica. 28-32.
- (2004). Cytoxic Effects of Myasthenia Gravis Patient Sera on Primary Human Skeletal Muscle Cell Cultures. Immunology. 131-134.
- (2003). Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis. Annals of the New York Academy of Sciences. 481-490.
- (2003). Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro. Muscle &Nerve. 81-89.
- (2003). Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies. Annals of the New York Academy of Sciences. 350-353.
- (2003). Myasthenia gravis in individuals over forty. Annals of the New York Academy of Sciences. 424-431.
- (2002). Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with co-stimulatory molecules. Journal of Neuroimmunology. 82-89.
- (2002). Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis. European Journal of Neurology. 55-61.
- (2001). Autoimmunity against the ryanodine receptor in myasthenia gravis. Acta Physiologica Scandinavica. 379-384.
- (2000). The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Archives of Neurology. 1596-1600.
- (2000). The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Archives of Neurology. 1596-1600.
- (2000). Skeletal muscle titin: physiology and pathophysiology. Cellular and Molecular Life Sciences (CMLS). 1570-1576.
- (2000). Skeletal muscle titin: physiology and pathophysiology. Cellular and Molecular Life Sciences (CMLS). 1570-1576.
- (2000). Muscle autoantibodies in subgroups of myasthenia gravis patients. Journal of Neurology. 369-375.
- (2000). Muscle autoantibodies in subgroups of myasthenia gravis patients. Journal of Neurology. 369-375.
- (2000). Complement activation by titin and ryanoidine receptor autoantibodies in myasthenia gravis. Journal of Neuroimmunology. 169-176.
- (2000). Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. Journal of Neuroimmunology. 169-176.
- (1999). TNFB polymorphisms in myasthenia gravis. Archives of Neurology. 457-461.
- (1998). Titin transcripts in thymoma. Annals of the New York Academy of Sciences. 422-426.
- (1998). The histomorphology of the thymus in late onset, non-thymoma myasthenia gravis. European Journal of Neurology. 401-405.
- (1998). Striational autoantibodies in myasthenia gravis patients recognizw I-band titin epitopes. Journal of Neuroimmunology. 98-108.
- (1998). Myasthenia gravis-associated ryanodine receptor antibodies inhibit binding of ryanodine to sarcoplasmic reticulum. Annals of the New York Academy of Sciences. 530-533.
- (1998). Myasthenia gravis sera containing anti-ryanodine receptor antibodies inhibit binding of (3H-) ryanodine to sarcoplasmic reticulum. Muscle and Nerve. 329-335.
- (1998). Muscle striation antibodies in myasthenia gravis; diagnostic and functional significance. Annals of the New York Academy of Sciences. 505-515.
- (1998). FcgRIIA and RIIIB polymorphisms in myasthenia gravis. Journal of Neuroimmunology. 173-176.
- (1998). Cell-mediated immune response against titin in myasthenia gravis; evidence for the involvment of Th1 and Th2 cells. Scandinavian Journal of Immunology. 76-82.
- (1998). Ataksi på grunn av vitamin E-mangel. Tidsskrift for Den norske legeforening. 3126-3128.
- (1997). Titin transcript in thymomas. Journal of Autoimmunity. 551-557.
- (1997). Titin antibody positive myasthenia gravis patients have a cellular immune response against the main immunogenic region of titin. European Journal of Neurology. 131-137.
- (1997). Diagnostikk av thymom og thymusatrofi hos pasienter med myasthenia gravis. Tidsskrift for Den norske legeforening. 4212-4214.
- (1997). Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes. Autoimmunity. 111-116.
Vitenskapelig foredrag
- (2022). Growth Dynamics of Incidental meningiomas. A 10 year prospective study.
- (2021). Growth Dynamics of Incidental meningiomas. A 10 year prospective study.
- (2013). Musikk, terapi og nevrologiske sykdommer.
- (2002). Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with co-stimulatory molecules.
- (2001). Thymectomy and muscle autoantibodies in myasthenia gravis.
- (2001). Gamma Knife Radiosurgery of meningiomas involving the cavernous sinus.
Populærvitenskapelig artikkel
- (2015). Musikk som terapi for ALS. Slagordet : tidsskrift for Landsforeningen for slagrammede.
Doktorgradsavhandling
- (2019). Complexity in Rhythm and Parkinson’s disease: Cognitive and Neuronal Correlates.
- (1998). Autoimmunity against titin and ryanodine receptor in myasthenia gravis. Clinical and immunological aspects. -.
Intervju
- (2013). Lydverket 25.06.2013. Hva skjer når vi skrur opp volumet og hører på høy musikk?
Programdeltagelse
- (2010). Schrødingers Katt, NRK: Musikk - magisk medisin.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
- (2011). Autoimmune neuromuscular transmission disorders. 12 sider.
- (2006). Autoimmune neuromuscular conduction disorders. 12 sider.
- (1997). Myasthenia gravis patients have a cellular immune response against titin. 8 sider.
- (1997). Accessory molecule expression in human thymomas and thymus. 6 sider.
Sammendrag/abstract
- (2009). Interleukin-10 promoter polymorphisms in myasthenia gravis. European Journal of Neurology. 49-49.
Poster
- (2022). DysfaSing! Music therapy pilot study to adress dysphagia cognitve function and psychological well-being in early stage of Huntington Disease.
- (2021). Long term results following Repeat Gamma Knife Surgery for Incompletely obliterated Arteriovenous Malformations after the first Gamma Knife treatment.
- (2018). Hyposmia and cognitive decline in early Parkinson's disease.
Errata
- (2019). Retraction Note to: Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms (Journal of Neurology, (2017), 264, 5, (955-962), 10.1007/s00415-017-8478-z). Journal of Neurology. 1555.
Vitenskapelig oversiktsartikkel/review
- (2016). Myasthenia gravis - Autoantibody characteristics and their implications for therapy. Nature Reviews Neurology. 259-268.
- (2011). Musikkterapi innen nevrorehabilitering - med vekt på hvordan plastisitet kan utnyttes :. Omsorg: Nordisk tidsskrift for Palliativ Medisin. 21-25.
- (2006). Unusual features in a boy with the rapsyn N88K mutation. Neurology. 2262-2263.